DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA

Clinical trials for DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.

Never miss a new study

Get alerted when new DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear

Sign up with your email to follow new studies for DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New eye drop aims to soothe painful scratches in rare skin disorder

Disease control Recruiting now

This study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin condition. Participants, including chil…

Matched conditions: DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA

Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA

Get alerted when new DEB - DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear

New eye drop aims to soothe painful scratches in rare skin disorder